Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.26
+0.10000.31%
Volume:351.10K
Turnover:11.23M
Market Cap:3.76B
PE:-6.91
High:32.34
Open:31.77
Low:31.70
Close:32.16
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.64
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.22
PE(LYR):-10.11

Loading ...

OverviewCompanyNewsFilings

Viking Therapeutics Inc - Company Expects to Report Phase 1 Study Results in Q3 2026

THOMSON REUTERS
·
Mar 26

Is It Too Late To Revisit Viking Therapeutics (VKTX) After Its Multi Year Surge?

Simply Wall St.
·
Mar 26

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 23

T-Mobile, AppLovin, ConocoPhillips, Viking, Western Digital Insider Shake-Up

TIPRANKS
·
Mar 14

Why Viking Therapeutics (VKTX) Is Up 12.6% After Fast-Tracking VK2735 Into Late-Stage Obesity Trials - And What's Next

Simply Wall St.
·
Mar 14

Viking Therapeutics Phase 3 Obesity Move Tests VK2735 Valuation Gap

Simply Wall St.
·
Mar 12

Leading Pharmaceutical Firms Race to Launch Oral Weight-Loss Medications

Deep News
·
Mar 06

FACTBOX-Top pharma companies racing to launch a weight-loss pill

Reuters
·
Mar 06

Viking Therapeutics to Join Leerink Global Healthcare Conference 2026 Fireside Chat in Miami

Reuters
·
Mar 06

Viking Therapeutics management to meet with Truist

TIPRANKS
·
Mar 04

Analyst Rate

Buy
Buy
90.00%
Hold
10.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Jul 29, 2026 Post-Mkt
Financial Report Announcement
Apr 29, 2026 Post-Mkt
Financial Report Announcement
Feb 11, 2026 Post-Mkt
Financial Report Announcement
Oct 22, 2025 Post-Mkt
Financial Report Announcement
Jul 23, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-6.91
Current
-24.95
Sector Average
77.07%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-6.91
Maximum
-3.02
+1 STD
-0.62
Minimum
-106.10
-1 STD
-49.27
Average
-24.95

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.